carmustine has been researched along with Left Ventricular Dysfunction in 4 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Doxorubicin plus paclitaxel has been shown to be an active regimen for metastatic breast cancer and is now frequently used as adjuvant therapy for high-risk primary breast cancer." | 9.09 | Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer. ( Abella, E; Baynes, RD; Cassells, L; Dansey, RD; Du, W; Hamm, C; Karanes, C; Klein, JL; Peters, WP; Rey, PM, 2000) |
| "Doxorubicin plus paclitaxel has been shown to be an active regimen for metastatic breast cancer and is now frequently used as adjuvant therapy for high-risk primary breast cancer." | 5.09 | Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer. ( Abella, E; Baynes, RD; Cassells, L; Dansey, RD; Du, W; Hamm, C; Karanes, C; Klein, JL; Peters, WP; Rey, PM, 2000) |
| "Cardiotoxicity is potentially the most threatening nonhaematological side effect of high-dose CY." | 1.33 | Very acute cardiac toxicity during BEAC chemotherapy in non-Hodgkin's lymphoma patients undergoing autologous stem cell transplantation. ( Ala-Kopsala, M; Hartikainen, J; Husso-Saastamoinen, M; Jantunen, E; Kuittinen, T; Nousiainen, T; Sipola, P; Vuolteenaho, O, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, PT | 1 |
| Chen, CL | 1 |
| Ren, P | 1 |
| Guarini, G | 1 |
| Chen, YR | 1 |
| Kuittinen, T | 2 |
| Husso-Saastamoinen, M | 1 |
| Sipola, P | 1 |
| Vuolteenaho, O | 2 |
| Ala-Kopsala, M | 2 |
| Nousiainen, T | 2 |
| Jantunen, E | 2 |
| Hartikainen, J | 2 |
| Vanninen, E | 1 |
| Mussalo, H | 1 |
| Klein, JL | 1 |
| Rey, PM | 1 |
| Dansey, RD | 1 |
| Karanes, C | 1 |
| Du, W | 1 |
| Abella, E | 1 |
| Cassells, L | 1 |
| Hamm, C | 1 |
| Peters, WP | 1 |
| Baynes, RD | 1 |
1 trial available for carmustine and Left Ventricular Dysfunction
| Article | Year |
|---|---|
Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carmustine; Cisplatin | 2000 |
3 other studies available for carmustine and Left Ventricular Dysfunction
| Article | Year |
|---|---|
BCNU-induced gR2 defect mediates S-glutathionylation of Complex I and respiratory uncoupling in myocardium.
Topics: Animals; Antineoplastic Agents, Alkylating; Cardiotoxins; Carmustine; Cattle; Cell Line; Electron Tr | 2014 |
Very acute cardiac toxicity during BEAC chemotherapy in non-Hodgkin's lymphoma patients undergoing autologous stem cell transplantation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cardiovascular System; Carmustine; Cycl | 2005 |
Cardiac effects within 3 months of BEAC high-dose therapy in non-Hodgkin's lymphoma patients undergoing autologous stem cell transplantation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Atrial Natriuretic Factor; Biomarkers; | 2006 |